Search Results - "Chapman, Jennifer Rose"

Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma by Matthews, Julie Marie, Bhatt, Shruti, Patricelli, Matthew P., Nomanbhoy, Tyzoon K., Jiang, Xiaoyu, Natkunam, Yasodha, Gentles, Andrew J., Martinez, Ezequiel, Zhu, Daxing, Chapman, Jennifer Rose, Cortizas, Elena, Shyam, Ragini, Chinichian, Shideh, Advani, Ranjana, Tan, Li, Zhang, Jianming, Choi, Hwan Geun, Tibshirani, Robert, Buhrlage, Sara J., Gratzinger, Dita, Verdun, Ramiro, Gray, Nathanael S., Lossos, Izidore S.

“…Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, yet 40% to 50% of patients will eventually succumb to their disease,…”
Get full text

De novo acute myeloid leukemia with monocytoid blasts and erythrophagocytosis by Blieden, Clifford, Fan, Yao‐Shan, Chapman, Jennifer Rose, Vega, Francisco

“…Key Clinical Message Acute myeloid leukemia (AML) with t(8:16) is an infrequent acute leukemia subtype. It can occur de novo or more frequently…”
Get full text

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma by Bhatt, Shruti, Ashlock, Brittany M., Natkunam, Yasodha, Sujoy, Victoria, Chapman, Jennifer Rose, Ramos, Juan Carlos, Mesri, Enrique A., Lossos, Izidore S.

“…Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma characterized by short survival with current therapies, emphasizing the urgent…”
Get full text

Primary malignant melanoma of the esophagus with separate foci of melanoma in situ and atypical melanocytic hyperplasia in a patient positive for human immunodeficiency virus: a case report and review of the literature by Fredricks, Jennifer Rose Chapman, Bejarano, Pablo A

“…Primary malignant melanoma of the esophagus (PMME) is a rare neoplasm. The primary nature of esophageal melanoma has been questioned in the past because most…”
Get full text

A Multicenter Study Analyzing Survival and Prognostic Factors in Patients with Leukemic Phase Follicular Lymphoma by Trabolsi, Asaad, Epperla, Narendranath, Annunzio, Kaitlin, Morgenstern Kaplan, Dan, Doukas, Peter, St-Pierre, Frederique, McCall, Brittany, Fitzgerald, Lindsey, Han, Sunwoo, Reis, Isildinha M., Chapman-Fredricks, Jennifer Rose, Alhamad, Khaled, Ollila, Thomas, Karmali, Reem, Lossos, Izidore S., Alderuccio, Juan Pablo

“…Introduction Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma. Leukemic-phase FL (LP-FL) is a rare entity comprising 1-3% of FL patients…”
Get full text

Germinal Center Kinase Regulates The Proliferation and Survival Of Diffuse Large B-Cell Lymphoma by Matthews, Julie Marie, Tan, Li, Bhatt, Shruti, Patricelli, Matthew, Nomanbhoy, Tyzoon, Zhang, Jianming, Jiang, Xiaoyu, Natkunam, Yasodha, Choi, Hwan Geun, Gentles, Andrew J., Martinez, Ezequiel, Zhu, Daxing, Chapman, Jennifer Rose, Shyam, Ragini M, Chinichian, Shideh, Advani, Ranjana H., Buhrlage, Sara, Gratzinger, Dita, Gray, Nathanael S, Lossos, Izidore S

“…Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). The pathogenesis of DLBCL represents a multi-step process that…”
Get full text

Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome by Malpica Castillo, Luis E, Campuzano-Zuluaga, German, Toomey, Ngoc L, Pimentel, Agustin, Chapman-Fredricks, Jennifer Rose, Ramos, Juan Carlos

“…Introduction: HTLV-1 related adult T-cell leukemia-lymphoma (ATLL) remains fatal, thus urging development of new therapies. Interferon regulatory factor 4…”
Get full text

Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL) by Malpica Castillo, Luis E, Campuzano-Zuluaga, German, Toomey, Ngoc L, Pimentel, Agustin, Alencar, Alvaro J., Chapman-Fredricks, Jennifer Rose, Ramos, Juan Carlos

“…▪ Introduction: Adult T-cell leukemia-lymphoma (ATLL) is caused by HTLV-1, and carries a dismal prognosis urging the development of new therapies. CD30…”
Get full text

LMO2 Facilitates Synthetic Lethality after PARP Inhibition (PARPi) in Diffuse Large B-Cell Lymphoma (DLBCL) by Verdun, Ramiro E, Parvin, Salma, Ramirez Labrada, Ariel, Santiago, Gabriel Emmanuel, Elena, Cortizas M, Eden, Sharabi, Shlomzion, Aumann, Yu, Zhang, Sanchez-Garcia, Isidro, Vega, Francisco, Chapman-Fredricks, Jennifer Rose, Lossos, Izidore S.

“…Novel therapies for DLBCL are needed to improve patients' outcomes. LIM domain only 2 (LMO2) protein is ubiquitously expressed and plays important roles in…”
Get full text

Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-κB Pathway by Cinar, Munevver, Rong, Hsiao-Rong, Chineke, Iloabueke, Louissaint, Abner, Chapman-Fredricks, Jennifer Rose, Vega, Francisco, Gunthel, Clifford James, Love, Cassandra, Mosunjac, Marina, Flowers, Christopher R, Dave, Sandeep, Lossos, Izidore S., Bernal-Mizrachi, Leon

“…Introduction: Plasmablastic lymphoma (PL) is an aggressive variant of lymphoma, with strong association with HIV. Despite significant improvements in the…”
Get full text

CD30 Expression Is Associated With Decreased Survival In Patients With Acute and Unfavorable Chronic Types Of Adult T-Cell Leukemia-Lymphoma by Campuzano-Zuluaga, German, Pimentel, Agustin, Diaz, Luis A, Chapman-Fredricks, Jennifer Rose, Ramos, Juan Carlos

“…Adult T-cell leukemia-lymphoma (ATLL) is a rare malignancy caused by the human T-lymphotropic virus type-1 (HTLV-I) which has a dismal prognosis, urging…”
Get full text

Primary malignant melanoma of the esophagus with separate foci of melanoma in situ and atypical melanocytic hyperplasia in a patient positive for human immunodeficiency virus: a case report and review of the literature by Fredricks, Jennifer Rose Chapman, Bejarano, Pablo A

Get full text

High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder by Chapman-Fredricks, Jennifer Rose, Cioffi-Lavina, Maureen, Accola, Molly A, Rehrauer, William M, Garcia-Buitrago, Monica T, Gomez-Fernandez, Carmen, Ganjei-Azar, Parvin, Jordà, Mercè

“…We reported previously that more than one-third (37%) of primary bladder squamous cell carcinomas (SCCs) demonstrate diffuse p16 immunoreactivity independent…”
Get full text